APA (7th ed.) Citation

G, M., AG, M., C, S., S, K., C, L., C, D., . . . Y, Y. (2022). Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2. The Journal of infection, 85(4), e104. https://doi.org/10.1016/j.jinf.2022.06.033

Chicago Style (17th ed.) Citation

G, Martin-Blondel, et al. "Sotrovimab to Prevent Severe COVID-19 in High-risk Patients Infected with Omicron BA.2." The Journal of Infection 85, no. 4 (2022): e104. https://doi.org/10.1016/j.jinf.2022.06.033.

MLA (9th ed.) Citation

G, Martin-Blondel, et al. "Sotrovimab to Prevent Severe COVID-19 in High-risk Patients Infected with Omicron BA.2." The Journal of Infection, vol. 85, no. 4, 2022, p. e104, https://doi.org/10.1016/j.jinf.2022.06.033.